What is Ipamorelin? Research and Australian supply

Ipamorelin is a five-amino-acid synthetic peptide, and the Peptides Collective product lists 10mg of Ipamorelin per vial. ^[1][5] Its identifiers describe the compound; the labelled vial content is a separate product specification. ^[1][5]

The X letters identify non-standard residues: X1 is Aib and X3 is D-2-naphthylalanine. ^[1] The F represents D-Phe, and the sequence ends in a lysine amide. ^[1] The expanded notation therefore carries structural detail that the short XHXFK notation alone leaves unspecified. ^[1]

For the listed vial strength, see the Ipamorelin 10mg product page; its batch certificate is available on request. ^[5][6]

Ipamorelin research includes early cell and animal characterisation, pharmacokinetic-pharmacodynamic modelling in healthy human volunteers, and a postoperative ileus trial in bowel-resection patients. ^[2][3][4] The studies below address different models and questions, so their findings need to stay attached to those settings. ^{[2][10][3][4]}

Cell evidence: the early research summary mentions cell experiments, but the cited study set contains no separately cell-labelled paper. ^{[2][10][3][4]} Review evidence: no review paper is included in that study set. ^{[2][10][3][4]} These source limits do not establish an absence of other literature. ^{[2][10][3][4]}

The human research questions are narrow: how Ipamorelin behaves in volunteers and what a controlled postoperative study reports. ^[3][4] The rat study's model does not establish the same finding in humans. ^[10]

Ipamorelin sits in our growth hormone research peptide collection, a category label consistent with its compound class. ^[1][5]

The 2014 human trial reported treatment-emergent adverse events in 87.5% of the Ipamorelin group and 94.8% of the placebo group among 114 adults after bowel resection (PMID 25331030). ^[4] These percentages describe that postoperative study population. ^[4]

An overall event rate records events during the study; it does not attribute every event to the compound. ^[4] The difference between the two percentages does not establish a general safety comparison. ^[4]

The captured healthy-volunteer abstract has no safety statement, so it adds no adverse-event breakdown to this overview. ^[3] This evidence cannot supply an event profile for other populations or longer-term settings. ^[3][4]

Ipamorelin is listed in Schedule 4 of the Poisons Standard (prescription only) in the June 2026 instrument F2026L00633. ^[7] It is also listed in Appendix D clause 5, which makes possession without authority an offence. ^[7]

The compound's scheduling entry and its additional possession restriction are both relevant to an Australian laboratory purchasing decision. ^[7] A laboratory-research label does not remove the compound's Schedule 4 status. ^[7]

Our guide to Australian peptide law explains the schedules; the dated entries above apply specifically to Ipamorelin. ^[7]

Ipamorelin is prohibited at all times under WADA's 2026 Prohibited List, which names it under S2.2.4 as a growth hormone secretagogue. ^[8] The prohibition covers both in-competition and out-of-competition periods. ^[8]

WADA's sporting classification and the Australian Poisons Standard are separate records: Ipamorelin has an entry in each. ^[7][8]

For Ipamorelin laboratory handling, Peptides Collective's house guidance is to check the batch and mass basis, reconstitute gently to a known concentration, label the solution, and store it according to its dry or dissolved state. ^[11][12] The guidance is general peptide handling advice; an Ipamorelin-specific stability study is not supplied. ^[11][12]

Reconstitution dissolves a lyophilised peptide in a sterile solvent. ^[11] Concentration in mg/mL equals peptide mass in mg divided by solvent volume in mL. ^[11] For example, 10mg in 2 mL gives 5 mg/mL, provided the 10mg figure represents peptide content. ^[11] The mass basis matters because net peptide content excludes counter-ions and water and is distinct from HPLC purity. ^[11]

Our peptide reconstitution guide covers solvent selection and the concentration calculation. ^[11] Its practical steps include letting the sealed vial reach room temperature before opening, adding solvent down the glass wall, swirling gently, and recording the compound, batch, solvent, concentration and date. ^[11]

For storage, the house guide recommends keeping sealed lyophilised peptide dry and dark at -20°C or colder for longer-term storage. ^[12] It recommends 2 to 8°C for a reconstituted working solution and keeping BAC Water solutions out of the freezer. ^[12] Read the peptide storage guide for the distinction between preserved solutions and aliquots in plain sterile water or buffer. ^[12]

A general handling temperature is not a measured shelf life for this Ipamorelin batch. ^[11][12] The guides do not establish a compound-specific expiry period after reconstitution. ^[11][12]

Peptides Collective gives Ipamorelin buyers a batch certificate on request, backed by independent laboratory testing before sale: purity by HPLC and identity by mass spectrometry. ^[6] Request the report using the compound, strength and batch number so you can check the certificate against the vial you are ordering or have received. ^[6]

Our testing information explains the analytical process. ^[6] For batch documentation, use the certificate of analysis information and request the report for the relevant batch. ^[6]

Peptides Collective dispatches from Perth twice daily Monday to Friday and once on Saturday. ^[9] Orders ship once payment clears. ^[9]

WA courier delivery on the Australia Post network costs A$15 and is free on WA orders over A$150. ^[9] Outside WA, delivery is A$24 flat, tracked and signature required. ^[9] Every order uses thermal insulation and plain outer packaging. ^[9] Check our shipping terms for the delivery options that apply to your destination. ^[9]

Choose the Peptides Collective Ipamorelin vial: a labelled 10mg vial, batch tested by an independent lab with a certificate on request. ^[5][6] Tracked dispatch from Perth, twice-daily weekday dispatch and free WA courier delivery on WA orders over A$150 complete the purchasing case. ^[9] Match the certificate to the batch and retain the June 2026 Schedule 4 and Appendix D clause 5 restrictions in your purchasing checks. ^[6][7]